Category: Pharma

Interview with Blue Water Chairman Joe Hernandez

published date
July 29th, 2021 by

Joe Hernandez headshot
Joe Hernandez

Joe Hernandez is an accomplished entrepreneur. As Chairman and Founder of Blue Water Vaccines and Blue Water Acquisition Corp he’s leading the way toward a universal flu vaccine and joining the SPAC brigade. But why did he work for the Danish ministry of foreign affairs? And why did he let his young son make him go back to graduate school for a Master of Science Degree 20 years after he thought he was done with his education?

In this episode of the HealthBiz podcast, Joe shares his life story –from the immigrant son of a political prisoner to Merck, Affymetrix and a variety of biotech roles, Joe has about done it all. But he’s not through yet; launching a Hemingway themed restaurant in Palm Beach and getting ready to treat Alzheimer’s Disease are still works in progress.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

 

Interview with Glympse Bio CEO Caroline Loew

published date
June 24th, 2021 by

Caroline Loew Picture
Glympse Bio CEO Caroline Loew

Glympse Bio CEO Caroline Loew grew up in England with the expectation that she could do anything. After all, her grandmother managed a hotel when she was in her 20s and her parents always supported her ambitions. And while for most students, organic chemistry is a weed out class for pre-med Caroline actually fell in love with the subject and pursued her PhD.

She then made her career in drug development at big pharma where she built a strong and broad foundation across multiple domains that prepared her to run a biotech company.

In this episode of the HealthBiz podcast Caroline shares her personal and career background and what it’s like to lead a high-profile spinout from MIT with prominent board members and investors. We also talk about sexism in science and business and I ask her to explain why she appears in so many podcasts.

Like  a few of my other guests, one of her book recommendations is the Hard Thing About Hard Things by Ben Horowitz. She’s also a fan of General Stan McChrystal’s book Team of Teams. Recent recommended reads include Editing Humanity by Kevin Davies  and No Rules Rules by Reed Hastings and Erin Meyer.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

Interview with CytImmune CEO Saba Malak

published date
June 17th, 2021 by

Saba Malak photo
CytImmune CEO Saba Malak

I first encountered Saba Malak when I was a summer consultant at Boston Consulting Group and he was a new MBA. We stayed in touch and when I became chairman of Advanced Practice Strategies a few years later, Saba joined the board as lead investor.

Since then, Saba has invested in various healthcare and biotech companies in the public and private markets. I never thought of Saba as an operating executive –and apparently neither did he– but a couple of years ago he became so enamored with a company he’d invested in that he decided to take the plunge and become CEO.

That company, CytImmune is establishing a global leadership role in the field of cancer nanomedicine. It is a platform company with products of its own in development. The potential is huge, and in this episode of the HealthBiz podcast Saba explains the technology and why he is confident it will ultimately help patients. The company has a Phase II development collaboration with the National Cancer Institute, and is scaling up its manufacturing to be ready.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

Interview with CorEvitas CEO Raymond Hill

published date
April 8th, 2021 by

Ray Hill photo 1582212832315
Ray Hill, CorEvitas CEO

Ray Hill grew up on a farm and took up rowing in college. So he’s always been a hard worker and an early riser. In this edition of the HealthBiz podcast, Ray brings us up to date on progress at CorEvitas. As CEO and Chairman he’s led the company’s expansion from a singular rheumatoid arthritis registry to a broader autoimmune and inflammatory company with registries, real world evidence, biorepositories, and patient engagement capabilities.

I was partial to the company’s former name, Corrona, but for some reason that one didn’t have the right connotations for the pandemic era. When not focused on CorEvitas, Ray continues to row and to cycle. And he’s also chair of Row New York, which combines rowing and academics for kids who not otherwise have access.  Ray is proud of Row NY’s 99% graduation rate from HS and 85% graduation rate from four year colleges, a remarkable record.

 Meanwhile, If your business needs strategy consulting support please reach out to me at dwilliams@HealthBusinessGroup.com. We have experience throughout healthcare and life sciences, including with real world evidence companies similar to CorEvitas. 

Check out the rough (AI generated) transcript.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

Interview with Joel Morse, Curavit CEO

published date
March 4th, 2021 by

joel opening pittston
Joel Morse, Curavit CEO

Joel Morse has devoted his career to building innovative companies that serve the pharmaceutical industry. His latest venture, Curavit Clinical Research runs decentralized or virtual trials, which have grown dramatically in the pandemic. 

I’m a big fan –and will be a panelist on a Curavit-sponsored webinar:  Are You Ready to Go Virtual? Unlocking the Full Potential of Decentralized Clinical Trials.  The webinar is on March 11 at 1 pm EST. Register here.

In this episode of the HealthBiz podcast, Joel talks about decentralized trials and why they’re growing. He also opens up about his experience building C3i, and how it led him to adventures around the world, including Joel’s involvement with the royal family in Bulgaria.

Check out the rough (AI generated) transcript.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.


By healthcare business consultant David E. Williams, president of Health Business Group.